Skip to main content

Table 1 Pa tient and VOI tumor details and dose results

From: Tumor and red bone marrow dosimetry: comparison of methods for prospective treatment planning in pretargeted radioimmunotherapy

Pt. # Age (years) Gender Location of VOI tumor AA (GBq) Volume of VOI tumor (mL) tox 3D-RD OLINDA
grade thr - grade leuc AD tumor (Gy) AD RBM (Gy) AD tumor (Gy)
7 63 F Rectum 6.2 14 0 - 0 0.73 0.39 0.71
10 70 M Liver 7.4 70 4 - 1 2.94 0.51 2.67
11 55 F Liver 7.4 44 0 - 0 2.53 0.29 2.47
12 70 M Liver 7.4 386 0 - 0 1.54 0.30 1.47
13 76 M Colon 7.4 23 0 - 0 0.51 0.12 0.51
14 52 F Liver 4.0 23 1 - 0 3.70 0.70 3.72
15 58 M Liver 5.9 285 1 - 0 0.86 0.58 0.83
16 76 M Colon 4.6 121 3 - 2 0.66 0.97 0.64
17 73 M Lung 4.5 65 2 - 0 0.63 0.43 0.62
18 63 F Liver 2.5 104 0 - 2 4.52 0.47 4.44
19 66 F Liver 7.4 141 0 - 0 1.45 0.28 1.38
20 72 M Lung 5.6 723 1 - 0 0.46 0.72 0.45
21 39 F Liver 5.6 154 0 - 0 2.47 0.23 2.45
Mean 64     166   1.77 0.46 1.72
  1. RBM = red bone marrow. AA = administered activity, Pt. # = patient number, tox = toxicity, grade thr = grade thrombocytopenia, grade leuc = grade leucopenia.